Federated Hermes, Inc. Avrobio, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$0.76 - $1.82 $4,306 - $10,312	-5,666 Reduced 78.9%	1,515 $1,000
Q4 2022 Feb 13, 2023	SELL	$0.64 - $0.91 $1,510 - $2,147	-2,360 Reduced 24.74%	7,181 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.68 - $1.11 $116 - $189	171 Added 1.82%	9,541 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $1.83 Million - $3.24 Million	-2,439,645 Reduced 99.62%	9,370 $9,000
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $188,905 - $591,609	-146,438 Reduced 5.64%	2,449,015 $3.23 Million
Q4 2021 Feb 14, 2022	BUY	$3.45 - $6.05 $714,401 - $1.25 Million	207,073 Added 8.67%	2,595,453 $9.99 Million
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $202,243 - $339,388	-36,572 Reduced 1.51%	2,388,380 $13.3 Million
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $1.13 Million - $1.82 Million	144,181 Added 6.32%	2,424,952 $21.6 Million
Q1 2021 May 13, 2021	BUY	$10.54 - $19.3 $10.8 Million - $19.8 Million	1,027,771 Added 82.02%	2,280,771 $28.9 Million
Q4 2020 Feb 12, 2021	BUY	$12.79 - $17.1 $7.21 Million - $9.64 Million	563,873 Added 81.82%	1,253,000 $17.5 Million
Q3 2020 Nov 12, 2020	BUY	$12.99 - $19.41 $5.22 Million - $7.8 Million	401,927 Added 139.95%	689,127 $8.97 Million
Q2 2020 Aug 13, 2020	BUY	$12.19 - $22.96 $3.5 Million - $6.59 Million	287,200 New	287,200 $5.01 Million
Q1 2020 May 13, 2020	SELL	$10.08 - $27.21 $18,889 - $50,991	-1,874 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $23,385 - $39,208	1,792 Added 2185.37%	1,874 $38,000
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $1,157 - $1,922	82 New	82 $1,000
Q1 2019 May 10, 2019	SELL	$12.46 - $22.05 $1,233 - $2,182	-99 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$15.43 - $32.7 $1,527 - $3,237	99 New	99 $1,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account